期刊文献+

循环肿瘤细胞在结直肠癌方面的研究进展 被引量:3

Research progress of circulating tumor cells in colorectal cancer
下载PDF
导出
摘要 近年来,随着生活方式及饮食结构的变化,我国结直肠癌发病率和死亡率呈上升趋势。检测外周血液中循环肿瘤细胞(CTC)对于结直肠癌的早期诊断、治疗效果监测、预后方面评估有重要意义。CTC是指因自发或诊疗操作脱离实体瘤从肿瘤原发灶或转移灶进入外周血循环中的肿瘤细胞。观察CTC数目变化对于结直肠癌的个体化诊疗有重要的临床意义。本文旨在对近年来CTC的检测技术及其在结直肠癌方面的诊断、治疗、预后的临床研究进展进行综述。 In recent years,with the changes of lifestyle and diet structure,the incidence and mortality of colorectal cancer in China are on the rise.The detection of circulating tumor cells (CTC) in peripheral blood has important significance for the early diagnosis,therapeutic effect monitoring and prognosis assessment of colorectal cancer.CTC refers to the tumor cells that have separated from solid tumor and entered the peripheral blood circulation from the primary tumor or metastatic tumor due to spontaneous or clinical operation.Observing the number changes of CTC has important clinical significance for the individualized diagnosis and treatment of colorectal cancer.This article aims to review the recent progress of CTC detection technology and clinical research on diagnosis,treatment and prognosis of colorectal cancer.
作者 张月 韩振国 ZHANG Yue;HAN Zhenguo(Department of General Surgery,Shanxi Dayi Hospital Affiliated to Shanxi Medical University,Shanxi Province,Taiyuan 030000,China)
出处 《中国医药导报》 CAS 2019年第22期62-65,共4页 China Medical Herald
基金 山西省重点研发计划项目(201603D321052)
关键词 结直肠癌 循环肿瘤细胞 预后 复发 转移 Colorectal cancer Circulating tumor cells Prognosis Recurrence Transfer
  • 相关文献

参考文献15

二级参考文献110

  • 1周剑,王锡山.结直肠癌外周血循环肿瘤细胞的研究进展[J].中华结直肠疾病电子杂志,2013,2(1):25-28. 被引量:2
  • 2王晓娜,梁寒,王家仓,王宝贵.1829例结直肠癌患者的临床病理特征及预后分析[J].中华胃肠外科杂志,2004,7(6):439-442. 被引量:36
  • 3宋恕平,刘波.晚期结直肠癌内科治疗进展[J].中国癌症杂志,2006,16(10):775-780. 被引量:11
  • 4张京平,朱春富,王克俊,徐皓,王仕忠,朱平,高翔,吴文泽.手术操作对胃癌细胞外周血播散的影响及其危险因素[J].中华胃肠外科杂志,2007,10(3):234-237. 被引量:1
  • 5Kohne CH, Wils J , LorenzM , et al. Randomized phase Ⅲ study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovor-in in advauced colorectal cancer: European Organization of Research and Treatment of Cancer Gastro intestinal Group Study 40952[J]. J Clin Oncol, 2003, 21 (20) : 3721-3728.
  • 6Van Cutsem E, Hoff PM , Harper P, et al. Oral eapecitabinevs intravenous 5-fluorouracil and leueovorin : integrated efficacy data and novel analyses from two large, randomized, phase Ⅲ trials[J]. Br J Cancer, 2004, 90 (6) : 1190-1197.
  • 7Arkenau H. , Schmoll H. , Kubicka S. , et al. Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC) : Results of the safety anti efficacy analysis[ J]. Proc Am Soc Cfin Oncol, 2005 :abstr 3507.
  • 8Popa EC. , Luo W;Hoehster H, , B,et al. A phase Ⅱ studv of ORZEL ( UFT + LV) in elderly ( = 75 years old ) patients with colorectal cancer:results of ECOG 1299 [ J]. Proe Am Soc Clin Oncol, 2005 :Abstr 3608.
  • 9Goldberg RM, Sargent DJ, Morton RF, et ai. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer[ J]. J Clin Oncol ,2004,22:23-30.
  • 10Chan Ray T, Au Gordon K, Kwok Carol C, et al. Fornightly CPT-11 plus 5FU and leucovorin as first-line therapy in Chinese patients with advanced colorectal cancer (ACRC) : effieacy and toxicity data from CPT, HKI. 602, a prospective phase Ⅱ study[J]. Proc Am Soc Clin Oncol,2002, 21 :Abstr 2329.

共引文献158

同被引文献53

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部